Application of Cephaloziellins H in preparation of prostate cancer treating medicine

A technology of cephaloziellinsh and 1.cephaloziellinsh, which can be applied in the directions of drug combination, antitumor drug, medical formula, etc., can solve the problem that there is no report on the activity of prostate cancer, etc.

Inactive Publication Date: 2015-12-16
刘高志
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] There is no report on the activity of this compound in the treatment of prostate cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Cephaloziellins H in preparation of prostate cancer treating medicine
  • Application of Cephaloziellins H in preparation of prostate cancer treating medicine
  • Application of Cephaloziellins H in preparation of prostate cancer treating medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Example 1: Isolation, Preparation and Structure Confirmation of CephaloziellinsH

[0013] The preparation method of Cephaloziellins H is the same as that reported in the literature (Secondary Metabolites from the Chinese Liverwort Cephaloziellakiaeri, J. Nat. Prod., 2013, 76, 1700-1708).

[0014] Confirmation of structure: colorless crystal (methanol), melting point 150-153°C. According to HR-ESI-MS, the molecular formula is C 20 h 22 o 7 , with an unsaturation of 10. H NMR spectrum data δ H (ppm, DMSO-d 6 , 600MHz): H-1 (1.81, m), H-1 (1.65, m), H-2 (2.23, 2H, m), H-3 (6.74, dd, J=3.6, 3.0), H- 6 (4.62, dd, J=10.2, 6.6), H-7 (1.95, dd, J=13.8, 6.6), H-7 (2.08, dd, J=13.8, 10.2), H-9 (2.48, dd , J=9.0, 7.2), H-11 (2.53, dt, J=13.0, 7.2), H-11 (2.19, ddd, J=13.0, 9.0, 6.0), H-12 (5.36, dd, J= 7.2, 6.0), H-14 (6.27, br, s), H-15 (7.33, br, s), H-16 (7.35, br, s), H-17 (1.42, s), H-19 (1.26, s); C NMR spectrum data δ C (ppm, DMSO-d 6 , 150Hz): 33.3 (CH 2 , 1-C)...

Embodiment 2

[0015] Embodiment 2: Pharmacological action test of Cephaloziellins H

[0016] 1. Materials and Instruments

[0017] Prostate cancer cell line PC3 (ArCC-CRL-1435), prostate cancer cell line DU145 (ATCC-HTB-81). CephaloziellinsH is self-made, and the HPLC normalized purity is greater than 98%. It is prepared into a storage solution with a concentration of 1.0 g / L with dimethylsulfoxide (DMSO) for future use. The CCK-8 kit is a product of Japan Tongren Chemical Research Institute. RPMI-1640 medium was purchased from Gibco. Fetal bovine serum (FBS) was purchased from Hyelone Company. Penicillin / streptomycin is a product of Shanghai Pioneer Pharmaceuticals. Trypsin was purchased from Huamei Bioengineering Company. Dimethyl sulfoxide (DMSO) was purchased from Shanghai Huashun Bioengineering Company. Agarose (Agarose), dithiothreitol (DTT), phenylmethylsulfonphthalein fluoride (PMSF), and tetramethylethylenediamine (TEMED) are products of Sigma. Sodium dodecylsulfonate (SDs),...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
Login to view more

Abstract

The invention discloses application of Cephaloziellins H in preparation of prostate cancer treating medicine, and belongs to the field of medicine. Researches show that Cephaloziellins H has an effect of inhibiting prostate cancer cell lines PC3 and DU145, and the effect has a concentration--time dependent relation, so that Cephaloziellins H can be further developed into preparation of prostate cancer treating medicine.

Description

technical field [0001] The invention relates to a new application of compound Cephaloziellins H, in particular to the application of Cephaloziellins H in the preparation of medicaments for treating prostate cancer. Background technique [0002] Rui-JuanLi et al. isolated and purified the compound Cephaloziellins H for the first time, and published the results in the famous Journal of Natural Products (Secondary Metabolites from the Chinese Liverwort Cephaloziellakiaeri, J. Nat. Prod., 2013, 76, 1700-1708). [0003] At present, there is no report about the activity of this compound in treating prostate cancer. Contents of the invention [0004] The purpose of the present invention is to provide a medical application of Cephaloziellins H. [0005] The above-mentioned purpose is achieved through the following technical solutions: [0006] Application of CephaloziellinsH in the preparation of a drug for treating prostate cancer, the chemical structural formula of the Cephalo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/365A61P35/00C07D493/04
Inventor 刘高志
Owner 刘高志
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap